
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
cadherin-24 CRISPR/Cas9 KO Plasmid (h) | sc-401990 | 20 µg | $397.00 |
CDH24 encodes cadherin-24, a calcium-dependent cell–cell adhesion protein that contributes to epithelial tissue organization by supporting adherens junction integrity and contact-dependent signaling. Through cadherin-mediated interactions with catenins and the actin cytoskeleton, cadherin-24 influences processes such as cell polarity, barrier function, and coordinated cell migration. Dysregulated cadherin expression patterns can alter intercellular cohesion and signaling networks linked to epithelial remodeling and invasion-associated phenotypes. CDH24 is therefore of interest for studying adhesion-dependent regulation of tissue architecture and disease-relevant changes in cellular behavior.
cadherin-24 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CDH24 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CDH24 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CDH24 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish cadherin-24 protein expression.
This CRISPR knockout system enables efficient generation of CDH24-deficient cell models for investigation of cadherin-24 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.